WO1992017168A1 - Method of preventing nmda receptor-mediated ...,https://www.google.com/patents/WO1992017168A1?cl=es
EP1087768A1 - Verwendung von 1-(aminoalkyl)-3-chinoxalin-2-on ...,https://www.google.com/patents/EP1087768A1?cl=ru
WO2016064929A1 - Methods and compositions for dosing in ...,https://www.google.com/patents/WO2016064929A1
"EP0873321A1 - Neue amido-chinoxalindione, ihre herstellung und ...",https://www.google.com/patents/EP0873321A1?cl=it
WO2006099739A1 - Use of adnf polypeptides for treating peripheral ...,https://www.google.com/patents/WO2006099739A1?cl=pt
CA2875348A1 - Chemical suppressors of neurotoxicity in ...,https://www.google.com/patents/CA2875348A1?cl=ar
EP1628663B1 - Method for producing medicaments for reducing ...,https://www.google.com/patents/EP1628663B1?cl=en10
US20090092667A1 - Method for Reducing Amyloid Deposition ...,https://www.google.com/patents/US20090092667?cl=en17
"EP2094265A1 - Pyrroloy[1,2-a]imidazoledione effective in the ...",https://www.google.com/patents/EP2094265A1?cl=fi
EP0931056A1 - N-substituted-2-amino-4-phenyl-4-oxo-butanoic ...,https://www.google.com/patents/EP0931056A1?cl=es
